miR-369-3p Ameliorates Inflammation and Apoptosis in Intestinal Epithelial Cells via the MEK/ERK Signaling Pathway
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094288 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Viviana Scalavino und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, Castellana Grotte, 70013 Bari, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Apoptosis, MAP Kinase Signaling System, Intestinal Mucosa. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, the Italian Ministry of Health.
Abstract (Originalsprache)
Inflammatory Bowel Disease (IBD) is a group of chronic and recurrent inflammatory diseases characterized by prolonged inflammation of the intestinal tract. Although it has been proven that the immune system plays a crucial role in the pathogenesis of IBD, a defective intestinal epithelium is also responsible for chronic inflammation, hence causing an over-activation of the immune response. For this reason, a therapeutic approach that acts by improving impaired intestinal homeostasis could ensure a greater therapeutic efficacy in IBD. Mitogen-activated protein kinases (MAPKs) signaling pathways may be involved in the pathogenesis of IBD. It has been demonstrated that the inhibition of mitogen-activated protein kinase kinase 1 (MEK1) may be a potential treatment against IBD since it may restore the normal epithelial function and reduce apoptosis of intestinal epithelial cells (IECs). New therapeutic strategies are emerging including small molecules such as microRNAs (miRNAs). In this study, we aimed to demonstrate that miR-369-3p was able to modulate the MEK/ERK signaling pathway. As reported by in silico analysis, miR-369-3p was capable of pairing the 3’UTR of the MAP2K1 gene. In vitro analysis demonstrated that mimic transfection with miR-369-3p in epithelial cells downregulated the expression of MEK1, reduced the activation of ERK signaling, and modulated apoptosis of epithelial cells in response to TNF-α. Moreover, miR-369-3p significantly decreased the release of pro-inflammatory cytokine IL-8. These results support the potential of miR-369-3p to prevent apoptosis of IECs, responsible for a persistent inflammatory condition in IBD, highlighting its application value in the treatment of inflammatory disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Gastroenterology S. De Bellis, IRCCS Research Hospital, Via Turi 27, Castellana Grotte, 70013 Bari, Italy.
ORCID-Profile: Viviana Scalavino, Emanuele Piccinno, Gianluigi Giannelli, Grazia Serino
Förderung
- Ministero della Salute
- the Italian Ministry of Health
Zitieren
APA
Scalavino, V., Piccinno, E., Giannelli, G., & Serino, G. (2025). miR-369-3p Ameliorates Inflammation and Apoptosis in Intestinal Epithelial Cells via the MEK/ERK Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094288
Vancouver
Scalavino V, Piccinno E, Giannelli G, Serino G. miR-369-3p Ameliorates Inflammation and Apoptosis in Intestinal Epithelial Cells via the MEK/ERK Signaling Pathway. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094288
BibTeX
@article{Scalavino2025,
author = {Scalavino, Viviana and Piccinno, Emanuele and Giannelli, Gianluigi and Serino, Grazia},
title = {miR-369-3p Ameliorates Inflammation and Apoptosis in Intestinal Epithelial Cells via the MEK/ERK Signaling Pathway},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094288}
}
EUVIMED